Inhibition of calcium-independent phospholipase A2 activates p38 MAPK signaling pathways during cytostasis in prostate cancer cells

Biochemical Pharmacology

Volumn 79, Issue 12, 2010, Pages 1727-1735

  Sun, Bin ^a   Zhang, Xiaoling ^a   Yonz, Christopher ^a   Cummings, Brian S ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Ca2+ independent phospholipase A2; Mitogen activated protein kinases; P38; Prostate cancer; Reactive species

Indexed keywords

ACETYLCYSTEINE; BROMOENOL LACTONE; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P21; PROTEIN P53; SMALL INTERFERING RNA; SYNAPTOPHYSIN;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; CYTOSTASIS; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION;

CELL CYCLE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; NAPHTHALENES; P21-ACTIVATED KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT; PROSTATIC NEOPLASMS; PYRONES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77951294329     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.02.005     Document Type: Article

References (45)

1. Cummings B.S. Phospholipase A2 as targets for anti-cancer drugs. Biochem Pharmacol 2007, 74:949-959.
2. Schaloske R.H., Dennis E.A. The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta 2006, 1761:1246-1259.
3. Saavedra G., Zhang W., Peterson B., Cummings B.S. Differential roles for cytosolic and microsomal Ca2+-independent phospholipase A2 in cell growth and maintenance of phospholipids. J Pharmacol Exp Ther 2006, 318:1211-1219.
4. Zhang X.H., Zhao C., Seleznev K., Song K., Manfredi J.J., Ma Z.A. Disruption of G1-phase phospholipid turnover by inhibition of Ca2+-independent phospholipase A2 induces a p53-dependent cell-cycle arrest in G1 phase. J Cell Sci 2006, 119:1005-1015.
5. Song Y., Wilkins P., Hu W., Murthy K.S., Chen J., Lee Z., et al. Inhibition of calcium-independent phospholipase A2 suppresses proliferation and tumorigenicity of ovarian carcinoma cells. Biochem J 2007, 406:427-436.
6. Sun B., Zhang X., Talathi S., Cummings B. Inhibition of Ca2+-independent phospholipase A2 decreases prostate cancer cell growth by p53-dependent and -independent mechanisms. J Pharmacol Exp Ther 2008, 326:59-68.
7. Chen Z., Gibson T.B., Robinson F., Silvestro L., Pearson G., Xu B., et al. MAP kinases. Chem Rev 2001, 101:2449-2476.
8. Reinhardt H.C., Aslanian A.S., Lees J.A., Yaffe M.B. p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 2007, 11:175-189.
9. Bae I.H., Kang S.W., Yoon S.H., Um H.D. Cellular components involved in the cell death induced by cisplatin in the absence of p53 activation. Oncol Rep 2006, 15:1175-1180.
10. Seger R., Krebs E.G. The MAPK signaling cascade. Faseb J 1995, 9:726-735.
11. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994, 369:156-160.
12. Frasch S.C., Nick J.A., Fadok V.A., Bratton D.L., Worthen G.S., Henson P.M. p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J Biol Chem 1998, 273:8389-8397.
13. Krishna M., Narang H. The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell Mol Life Sci 2008, 65:3525-3544.
14. Fan M., Chambers T.C. Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy. Drug Resist Updat 2001, 4:253-267.
15. Chang H.L., Wu Y.C., Su J.H., Yeh Y.T., Yuan S.S. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2. J Pharmacol Exp Ther 2008, 325:841-849.
16. Bradham C., McClay D.R. p38 MAPK in development and cancer. Cell Cycle 2006, 5:824-828.
17. Brown L., Benchimol S. The involvement of MAPK signaling pathways in determining the cellular response to p53 activation: cell cycle arrest or apoptosis. J Biol Chem 2006, 281:3832-3840.
18. Kim B.J., Ryu S.W., Song B.J. JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem 2006, 281:21256-21265.
19. Woo K.J., Lee T.J., Lee S.H., Lee J.M., Seo J.H., Jeong Y.J., et al. Elevated gadd153/chop expression during resveratrol-induced apoptosis in human colon cancer cells. Biochem Pharmacol 2007, 73:68-76.
20. Oh-Hashi K., Maruyama W., Isobe K. Peroxynitrite induces GADD34, 45, and 153 VIA p38 MAPK in human neuroblastoma SH-SY5Y cells. Free Radic Biol Med 2001, 30:213-221.
21. Yellaturu C.R., Rao G.N. A requirement for calcium-independent phospholipase A2 in thrombin-induced arachidonic acid release and growth in vascular smooth muscle cells. J Biol Chem 2003, 278:43831-43837.
22. Beckett C.S., Pennington K., McHowat J. Activation of MAPKs in thrombin-stimulated ventricular myocytes is dependent on Ca2+-independent PLA2. Am J Physiol Cell Physiol 2006, 290:C1350-C1354.
23. Aoto M., Shinzawa K., Suzuki Y., Ohkubo N., Mitsuda N., Tsujimoto Y. Essential role of p38 MAPK in caspase-independent, iPLA2-dependent cell death under hypoxia/low glucose conditions. FEBS Lett. 2009, 583:1611-1618.
24. Xu J., Weng Y.I., Simonyi A., Krugh B.W., Liao Z., Weisman G.A., et al. Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. J Neurochem 2002, 83:259-270.
25. Han W.K., Sapirstein A., Hung C.C., Alessandrini A., Bonventre J.V. Cross-talk between cytosolic phospholipase A2 alpha (cPLA2 alpha) and secretory phospholipase A2 (sPLA2) in hydrogen peroxide-induced arachidonic acid release in murine mesangial cells: sPLA2 regulates cPLA2 alpha activity that is responsible for arachidonic acid release. J Biol Chem 2003, 278:24153-24163.
26. Hassan S., Carraway R.E. Involvement of arachidonic acid metabolism and EGF receptor in neurotensin-induced prostate cancer PC3 cell growth. Regul. Peptides 2006, 133:105-114.
27. Cummings B.S., Schnellmann R.G. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther 2002, 302:8-17.
28. Murrant C.L., Reid M.B. Detection of reactive oxygen and reactive nitrogen species in skeletal muscle. Microsc Res Tech 2001, 55:236-248.
29. Oyama Y., Hayashi A., Ueha T., Maekawa K. Characterization of 2′,7′-dichlorofluorescin fluorescence in dissociated mammalian brain neurons: estimation on intracellular content of hydrogen peroxide. Brain Res 1994, 635:113-117.
30. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150:76-85.
31. Zhang L., Peterson B.L., Cummings B.S. The effect of inhibition of Ca2+-independent phospholipase A2 on chemotherapeutic-induced death and phospholipid profiles in renal cells. Biochem Pharmacol 2005, 70:1697-1706.
32. Bao S., Bohrer A., Ramanadham S., Jin W., Zhang S., Turk J. Effects of stable suppression of group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells. J Biol Chem 2006, 281:187-198.
33. Jing Q., Xin S.-M., Cheng Z.-J., Zhang W.-B., Zhang R., Qin Y.-W., et al. Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells: mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity. Circ Res 1999, 84:831-839.
34. Bhat N.R., Zhang P. Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death. J Neurochem 1999, 72:112-119.
35. Balsinde J., Dennis E.A. Function and inhibition of intracellular calcium-independent phospholipase A2. J Biol Chem 1997, 272:16069-16072.
36. Kinsey G.R., Cummings B.S., Beckett C.S., Saavedra G., Zhang W., McHowat J., et al. Identification and distribution of endoplasmic reticulum iPLA2. Biochem Biophys Res Commun 2005, 327:287-293.
37. Kinsey G.R., McHowat J., Patrick K.S., Schnellmann R.G. Role of Ca2+-independent phospholipase A2gamma in Ca2+-induced mitochondrial permeability transition. J Pharmacol Exp Ther 2007, 321:707-715.
38. Kinsey G.R., Blum J.L., Covington M.D., Cummings B.S., McHowat J., Schnellmann R.G. Decreased iPLA2gamma expression induces lipid peroxidation, cell death, and sensitizes cells to oxidant-induced apoptosis. J Lipid Res 2008, 49:1477-1487.
39. Eastham J.A., Stapleton A.M., Gousse A.E., Timme T.L., Yang G., Slawin K.M., et al. Association of p53 mutations with metastatic prostate cancer. Clin Cancer Res 1995, 1:1111-1118.
40. Zhang X.H., Zhao C., Ma Z.A. The increase of cell-membranous phosphatidylcholines containing polyunsaturated fatty acid residues induces phosphorylation of p53 through activation of ATR. J Cell Sci 2007, 120:4134-4143.
41. Cummings B.S., McHowat J., Schnellmann R.G. Role of an endoplasmic reticulum Ca(2+)-independent phospholipase A(2) in oxidant-induced renal cell death. Am J Physiol Renal Physiol 2002, 283:F492-F498.
42. Song H., Bao S., Ramanadham S., Turk J. Effects of biological oxidants on the catalytic activity and structure of group VIA phospholipase A2. Biochemistry 2006, 45:6392-6406.
43. Hooks S.B., Cummings B.S. Role of Ca2+-independent phospholipase A2 in cell growth and signaling. Biochem Pharmacol 2008, 76:1059-1067.
44. Yeo J.E., Kang S.K. Selenium effectively inhibits ROS-mediated apoptotic neural precursor cell death in vitro and in vivo in traumatic brain injury. Biochim Biophys Acta 2007, 1772:1199-1210.
45. Berti-Mattera L.N., Harwalkar S., Hughes B., Wilkins P.L., Almhanna K. Proliferative and morphological effects of endothelins in Schwann cells: roles of p38 mitogen-activated protein kinase and Ca(2+)-independent phospholipase A2. J Neurochem 2001, 79:1136-1148.